RECURRENT HEPATOCELLULAR CARCINOMA
Clinical trials for RECURRENT HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Liver cancer drug trial for transplant patients halted early
Disease control TerminatedThis study tested the drug lenvatinib in people whose liver cancer returned after a liver transplant. The goal was to see if the drug could shrink tumors. However, the trial was stopped early after enrolling only 3 participants, so we don't have enough information to know if it w…
Matched conditions: RECURRENT HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 05:46 UTC
-
Proton therapy for liver cancer: early trial halted
Disease control TerminatedThis study tested a precise type of proton radiation (SBPT) for people with liver cancer that had not spread. The goal was to see if this treatment caused fewer liver problems than standard radiation. The trial was stopped early after enrolling only 9 participants, so the results…
Matched conditions: RECURRENT HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 19, 2026 11:48 UTC